Anna Scuto

3.0k citations

30 papers · 2.2k indexed · h-index 19

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Oncology top 5%
- Cytokine Signaling Pathways and Interactions

Papers in ⓘ

Hematology 9
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 5
Oncology 14
- Cytokine Signaling Pathways and Interactions 7
- Cancer-related Molecular Pathways 4

Co-authors: Richard Jove (14 shared papers)Stephen J. Forman (10 shared papers)Claudia Kowolik (6 shared papers)Celia Sigua (5 shared papers)Kapil N. Bhalla (5 shared papers)Fei Guo (5 shared papers)Warren Fiskus (5 shared papers)Srinivas Annavarapu (5 shared papers)
Journals: Cancer Research (9 papers)Blood (9 papers)Molecular Cancer Therapeutics (2 papers)Molecular Oncology (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)
Partner nations: United States Italy Argentina

In The Last Decade

Anna Scuto

29 papers receiving 2.2k citations

Peers

Countries citing papers authored by Anna Scuto

Since Specialization

Citations

This map shows the geographic impact of Anna Scuto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Scuto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Scuto more than expected).

Fields of papers citing papers by Anna Scuto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Scuto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Scuto. The network helps show where Anna Scuto may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Scuto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Scuto Line = papers co-authored together Anna Scuto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses Nature Biotechnology ·Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, Lin Wang, Claudia Kowolik, Maciej Kujawski, Heehyoung Lee, Anna Scuto, Yong Liu, Chunmei Yang, Jiehui Deng, Harris S. Soifer, Andrew Raubitschek, Stephen J. Forman, John J. Rossi, Drew M. Pardoll, Richard Jove, Hua Yu	2009	302
2	Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3 Blood ·Prince George, Purva Bali, Srinivas Annavarapu, Anna Scuto, Warren Fiskus, Fei Guo, Celia Sigua, Gautam Sondarva, Lynn C. Moscinski, Peter Atadja, Kapil N. Bhalla	2004	273
3	Prediction of Radiation Sensitivity Using a Gene Expression Classifier Cancer Research ·Javier F. Torres–Roca, Steven A. Eschrich, Haiyan Zhao, Gregory Bloom, Jimmy C. Sung, Susan McCarthy, Alan Cantor, Anna Scuto, Changgong Li, Suming Zhang, Richard Jove, Timothy J. Yeatman	2005	173
4	Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cells Blood ·Fei Guo, Celia Sigua, Purva Bali, Prince George, Warren Fiskus, Anna Scuto, Srinivas Annavarapu, Abdelmoughite Mouttaki, Gautam Sondarva, Sheng Wei, Jie Wu, Julie Y. Djeu, Kapil N. Bhalla	2004	140
5	The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph− acute lymphoblastic leukemia cells Blood ·Anna Scuto, Mark Kirschbaum, Claudia Kowolik, Leo Kretzner, Ágnes Juhász, Peter Atadja, Vinod Pullarkat, Ravi Bhatia, Stephen J. Forman, Yun Yen, Richard Jove	2008	119
6	Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3 Clinical Cancer Research ·Purva Bali, Prince George, Pamela Cohen, Jianguo Tao, Fei Guo, Celia Sigua, Anasuya Vishvanath, Anna Scuto, Srinivas Annavarapu, Warren Fiskus, Lynn C. Moscinski, Peter Atadja, Kapil N. Bhalla	2004	114
7	Cotreatment with 17-Allylamino-Demethoxygeldanamycin and FLT-3 Kinase Inhibitor PKC412 Is Highly Effective against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3 Cancer Research ·Prince George, Purva Bali, Pamela Cohen, Jianguo Tao, Fei Guo, Celia Sigua, Anasuya Vishvanath, Warren Fiskus, Anna Scuto, Srinivas Annavarapu, Lynn C. Moscinski, Kapil N. Bhalla	2004	113
8	Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects Cancer Research ·Maciej Kujawski, Chunyan Zhang, Andreas Herrmann, Karen L. Reckamp, Anna Scuto, Michael C. Jensen, Jiehui Deng, Stephen J. Forman, Robert A. Figlin, Hua Yu	2010	99
9	Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3 Molecular Cancer Therapeutics ·Fan Yang, Christine E. Brown, Ralf Buettner, Michael Hedvat, Renate Starr, Anna Scuto, Anne Schroeder, Michael C. Jensen, Richard Jove	2010	97
10	Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480 Cancer Research ·Xin Hong, Andreas Herrmann, Karen L. Reckamp, Wang Zhang, Sumanta K. Pal, Michael Hedvat, Chunyan Zhang, Wei Liang, Anna Scuto, Shaobu Weng, Deborah Morosini, Zhu Cao, Michael Zinda, Robert A. Figlin, Dennis Huszar, Richard Jove, Hua Yu	2011	93
11	6-Bromoindirubin-3′-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells Cancer Research ·Lucy Liu, Sangkil Nam, Yan Tian, Fan Yang, Jun Wu, Yan Wang, Anna Scuto, Panos Polychronopoulos, Prokopios Magiatis, Léandros Skaltsounis, Richard Jove	2011	92
12	STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma Cancer Research ·Anna Scuto, Maciej Kujawski, Claudia Kowolik, Ludmila Krymskaya, Lin Wang, Lawrence M. Weiss, David DiGiusto, Hua Yu, Stephen J. Forman, Richard Jove	2011	92
13	Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels Cancer Research ·Leo Kretzner, Anna Scuto, Pamela M. Dino, Claudia Kowolik, Jun Wu, Patrick Ventura, Richard Jove, Stephen J. Forman, Yun Yen, Mark Kirschbaum	2011	89
14	S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma Blood ·Yong Liu, Jiehui Deng, Lin Wang, Heehyoung Lee, Brian Armstrong, Anna Scuto, Claudia Kowolik, Lawrence M. Weiss, Stephen J. Forman, Hua Yu	2012	82
15	Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages Clinical Chemistry and Laboratory Medicine (CCLM) ·Michelino Di Rosa, Maria Musumeci, Anna Scuto, Salvatore Musumeci, Lucia Malaguarnera	2005	69
16	Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer Molecular Cancer Therapeutics ·Wei Wen, Wei Liang, Jun Wu, Claudia Kowolik, Ralf Buettner, Anna Scuto, Meng-Yin Hsieh, Hao Hong, Christine E. Brown, Stephen J. Forman, David Horne, Robert J. Morgan, Mark T. Wakabayashi, Thanh H. Dellinger, Ernest Han, John H. Yim, Richard Jove	2014	66
17	Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling Molecular Oncology ·Sangkil Nam, Anna Scuto, Fan Yang, Wenyong Chen, Sungman Park, Hwa‐Seung Yoo, Helmut König, Ravi Bhatia, Xinlai Cheng, Karl-Heinz Merz, Gerhard Eisenbrand, Richard Jove	2012	59
18	Carbamates: A study on genotoxic, cytotoxic, and apoptotic effects induced in Chinese hamster ovary (CHO-K1) cells Toxicology in Vitro ·Sonia Soloneski, Maciej Kujawski, Anna Scuto, Marcelo L. Larramendy	2015	32
19	Survivin expression in chronic myeloid leukemia Cancer Letters ·Enrico Conte, Fabio Stagno, Patrizia Guglielmo, Anna Scuto, Carla Consoli, Angelo Messina	2004	30
20	DNA damage kinetics and apoptosis in ivermectin‐treated chinese hamster ovary cells Journal of Applied Toxicology ·G. Molinari, Maciej Kujawski, Anna Scuto, Sonia Soloneski, Marcelo L. Larramendy	2012	16

About Anna Scuto

Anna Scuto is a scholar working on Hematology, Oncology, Genetics, Parasitology and Immunology, having authored 30 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Protein Degradation and Inhibitors (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Hematology (301 citations), Oncology (667 citations), Immunology (462 citations), Molecular Biology (1.4k citations) and Cancer Research (278 citations). Anna Scuto has collaborated with scholars based in United States, Italy and Argentina. Frequent co-authors include Richard Jove, Stephen J. Forman, Claudia Kowolik, Celia Sigua, Kapil N. Bhalla, Fei Guo, Warren Fiskus, Srinivas Annavarapu, Purva Bali and Prince George. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, Molecular Oncology and Clinical Chemistry and Laboratory Medicine (CCLM).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact